Toshitsugu Sugimoto

Medicine · Health Sciences

67h-index18.3kcitations476works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Bone health and osteoporosis research(186), Bone health and treatments(171), Bone Metabolism and Diseases(124), Parathyroid Disorders and Treatments(90), Bone and Joint Diseases(55)

Publications476 total

Supplementary Material for: Recurrence of large-vessel vasculitis induced by multiple types of Granulocyte colony-stimulating factor preparation in patient with large cell neuroendocrine lung carcinoma: a case report
Figshare·2023Open Access
Sequential therapy with once-weekly teriparatide injection followed by alendronate versus monotherapy with alendronate alone in patients at high risk of osteoporotic fracture: final results of the Japanese Osteoporosis Intervention Trial-05
Osteoporosis International·2022· 16 citedOpen Access
Association of Urinary Pentosidine Levels With the Risk of Fractures in Patients With Severe Osteoporosis: The Japanese Osteoporosis Intervention Trial‐05 ( <scp>JOINT</scp> ‐05)
JBMR Plus·2022· 6 citedOpen Access
Correction to: A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese osteoporosis intervention Trial-05
Osteoporosis International·2021· 1 citedOpen Access
Relationship Between Changes in Serum Levels of Intact Parathyroid Hormone and Sclerostin After a Single Dose of Zoledronic Acid: Results of a Phase 1 Pharmacokinetic Study
Calcified Tissue International·2021· 2 citedOpen Access
Acute Phase Reactions After Intravenous Infusion of Zoledronic Acid in Japanese Patients with Osteoporosis: Sub-analyses of the Phase III ZONE Study
Calcified Tissue International·2021· 19 citedOpen Access
A randomized, controlled trial of once-weekly teriparatide injection versus alendronate in patients at high risk of osteoporotic fracture: primary results of the Japanese Osteoporosis Intervention Trial-05
Osteoporosis International·2021· 51 citedOpen Access
Response to the letter from Otsuka et al. Trends in the prevalence of underweight in women across generations in Japan
Journal of Bone and Mineral Metabolism·2021
Efficacy of once-weekly and twice-weekly injections of teriparatide by patient characteristics: A post hoc analysis of the TWICE study
Osteoporosis and Sarcopenia·2021· 2 citedOpen Access
Which Is a Better Skeletal Muscle Mass Index for the Evaluation of Physical Abilities: The Present Height or Maximum Height?
Internal Medicine·2020· 8 citedOpen Access
A pregnant woman with an autonomously functioning thyroid nodule: a case report
Gynecological Endocrinology·2020· 4 cited
Executive summary of clinical practice guide on fracture risk in lifestyle diseases
Journal of Bone and Mineral Metabolism·2020· 20 cited
Randomized head-to-head comparison of minodronic acid and raloxifene for fracture incidence in postmenopausal Japanese women: the Japanese Osteoporosis Intervention Trial (JOINT)-04
Current Medical Research and Opinion·2020· 4 cited
High glucose promotes mineralization via bone morphogenetic protein 4-Smad signals in early stage of osteoblast differentiation
Diabetology International·2020· 14 citedOpen Access
Relationship Between Bone Mineral Density and Risk of Vertebral Fractures with Denosumab Treatment in Japanese Postmenopausal Women and Men with Osteoporosis
Calcified Tissue International·2020· 5 cited
Vitamin D intake is major determinant of the concentration of 25-hydroxyvitamin D in the serum of healthy postmenopausal women.
Endocrine Abstracts·2020
Efficacy of denosumab co-administered with vitamin D and Ca by baseline vitamin D status
Journal of Bone and Mineral Metabolism·2020· 13 cited
Graves’ disease and vertebral fracture: Possible pathogenic link in postmenopausal women
Clinical Endocrinology·2020· 9 cited
SUN-412 Graves’ Disease Displayed as a Risk Factor of Vertebral Fracture Even in Premenopausal Women
Journal of the Endocrine Society·2020· 1 citedOpen Access
Association between elcatonin use and cancer risk in Japan: A follow-up study after a randomized, double-blind, placebo-controlled study of once-weekly elcatonin in primary postmenopausal osteoporosis
Osteoporosis and Sarcopenia·2020· 3 citedOpen Access
page 1 of 24Next →

Frequent Co-authors

Toru Yamaguchi(20), Mika Yamauchi(20), Kazuo Chihara(15), Shozo Yano(13), Masahiro Yamamoto(12), Hiroshi Kaji(12), Ippei Kanazawa(10), Hiroshi Hagino(7), Hideaki Sowa(6), Masanori Kanatani(6), Toshio Matsumoto(6), Toshitaka Nakamura(5), Hiroaki Ohta(5), Masataka Shiraki(5), Satoshi Soen(5), Masao Fukunaga(5), Toshiyuki Yoneda(5), Seiji Fukumoto(4), Akimitsu Miyauchi(3), Soichi Kurioka(3)